NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
02/23/23 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
1 | |
02/17/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
![]() |
9 | |
02/17/23 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
![]() |
11 | |
01/31/23 | 3 | Initial statement of beneficial ownership of securities |
![]() |
2 | |
01/26/23 | EFFECT | Notice of Effectiveness |
![]() |
1 | |
01/24/23 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
![]() |
1 | |
01/20/23 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
4 |
01/05/23 | UPLOAD | SEC-generated letter |
![]() |
1 | |
01/03/23 | 8-K | Current report filing |
![]() |
![]() ![]() ![]() |
2 |
12/30/22 | S-3 | Registration statement for specified transactions by certain issuers |
![]() |
100 |